Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

SS Innovations Int'l pioneers pediatric telesurgery

SS Innovations International, Inc. has made a significant breakthrough in the field of surgical robotics. The company recently announced the successful completion of the world's first pediatric pyeloplasty telesurgery using its SSI Mantra surgical robotic system. Dr. Chandra Mohan Vaddi, managing director of Preeti Urology & Kidney Hospitals, performed the robotic procedure remotely from SS Innovations' headquarters in Gurugram, India, nearly 1,000 miles away from the 16-month-old patient located at Preeti Hospital in Hyderabad, India.

This achievement showcases the strengths of the SSI Mantra robotic system in telesurgery and highlights the potential opportunities for its application in pediatrics. The company's chairman and CEO, Dr. Sudhir Srivastava, emphasized the benefits of robotic surgery, including precision, minimally invasive procedures with smaller incisions, reduced pain, and faster recovery times, which are particularly crucial in pediatric and general surgery.

Notably, more than 50 telesurgeries have been performed using the SSI Mantra system, spanning various categories such as pediatric, cardiac, urology, gynecology, oncology, and general surgery. This demonstrates the versatility and effectiveness of the technology across a range of medical specialties. SS Innovations aims to address the unmet surgical robotic needs in the pediatric market and plans to further develop the SSI Mantra's capabilities in pediatric robotic surgery through the creation of smaller instrumentation.

As a company dedicated to making robotic surgery accessible to a larger segment of the global population, SS Innovations International, Inc. continues to expand its product range, which includes the SSI Mantra surgical robotic system and the SSI Mudra surgical instruments supporting various surgical procedures, including robotic cardiac surgery.

The successful pediatric pyeloplasty telesurgery represents a significant milestone for SS Innovations, underscoring its commitment to advancing surgical robotic technologies and bringing world-class care to underserved communities. As a result of these announcements, the company's shares have moved 3.7% on the market, and are now trading at a price of $5.60. For the full picture, make sure to review SS Innovations International's 8-K report.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS